US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist

21.920
+0.240+1.11%

Close Jan 17 16:00 ET

21.890
-0.030-0.14%

Post 20:01 ET

24.84BMarket Cap-25.79P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Teva Pharmaceutical Industries Q4 2024 Estimates Date

Currency：USDJan 29, 2025

	Estimate	YoY
Revenue	4.12B	-7.52%
EPS	0.31	-24.27%

Analyst Rating

Strong Buy

Jan 20, 2025

Teva Pharmaceutical Industries Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.857B	--
Jan 29, 2025	2024/Q4	-- / 4.122B	--
Nov 6, 2024	2024/Q3	4.332B / 4.125B	--
Jul 31, 2024	2024/Q2	4.164B / 4.045B	--
May 8, 2024	2024/Q1	3.819B / 3.740B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.857B--

Jan 29, 20252024/Q4-- / 4.122B--

Nov 6, 20242024/Q34.332B / 4.125B--

Jul 31, 20242024/Q24.164B / 4.045B--

May 8, 20242024/Q13.819B / 3.740B--

Unlock Free Earnings Estimates

Open Account

Teva Pharmaceutical Industries Earnings Reports

10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:15 ET

8-K: Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

Nov 6, 2024 07:02 ET

10-Q: Q2 2024 Earnings Report

Jul 31, 2024 16:11 ET

10-Q: Q1 2024 Earnings Report

May 8, 2024 17:14 ET